Skip to main content
. Author manuscript; available in PMC: 2014 Dec 12.
Published in final edited form as: Oncogene. 2013 Jul 15;33(24):3099–3108. doi: 10.1038/onc.2013.281

Fig. 1. Dicer is upregulated in prostate cancer, but relatively lower Dicer expression predicts poor clinical outcome.

Fig. 1

(A) qRT-PCR and Western blot analyses of Dicer expression in normal primary (PrEC) and immortalized (PNT1, and PNT2) prostate epithelial cells, and cancerous human prostate epithelial cell lines. (B) qRT-PCR analysis of Dicer expression in normal and cancerous human prostate specimens. * p = 0.0008, one way ANOVA t test. (C) Kaplan-Meier survival plot for correlation of Dicer expression with prostate cancer recurrence in 5 years. Log-rank test: p = 0.0096.